D. Chu

Statistics

Publications

Citations

133

H-Index

Active since

2009

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Chinese University of Hong Kong

D. Chu is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in pharmacotherapy, lung cancer, and chemotherapy.

ORCID

Publications per year

2009–2009

Publications

Biomarker analyses from a phase III, randomized, open-label, first-line study of gefitinib (G) versus carboplatin/paclitaxel (C/P) in clinically selected patients (pts) with advanced non-small cell lung cancer (NSCLC) in Asia (IPASS)

M. Fukuoka, Yi‐Cheng Wu, S. Thongprasert et al. · Journal of Clinical Oncology · 2009 · 119 citations

Medicine, Oncology, Pharmacotherapy +13

Evaluation of clinically selected patients (pts) with advanced non-small cell lung cancer (NSCLC) recruited in China in a phase III, randomized, open-label, first-line study in Asia of gefitinib (G) versus carboplatin/paclitaxel (C/P) (IPASS)

Yi‐Long Wu, Tony Mok, D. Chu et al. · Journal of Clinical Oncology · 2009 · 14 citations

Medicine, Oncology, Pharmacotherapy +16

1–2 of 2